-
Mashup Score: 16Delivering Discoveries: Updates in Oncology CME - UC San Diego Continuing Professional Development - Continuing Education (CE) - 7 month(s) ago
UC San Diego Continuing Professional Development, Delivering Discoveries: Updates in Oncology CME, 10/17/2024 7:00:00 AM – 10/18/2024 2:00:00 PM, The 3rd annual Delivering Discoveries: Updates in Oncology is a live meeting scheduled for October 17-18, 2024 at the Hilton La Jolla Torrey Pines in La Jolla, CA. The diagnosis and management of cancer patients is increasingly complex and requires multidisciplinary management. This 1.5-day event will address all aspects of cancer, from basic science research and advances in clinical care to community-based approaches that optimize prevention and interception. We have assembled a multidisciplinary group of internationally renowned faculty from UC San Diego, San Diego State University, and other institutions to systematically present the latest in cancer research with the goal of iteratively addressing and identifying gaps in knowledge that present a barrier to optimizing outcomes for patients with cancer.
Source: ucsd.cloud-cme.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Ratan Tata, of India's Tata conglomerate, dies at age 86 - 7 month(s) ago
Ratan Tata, the former Tata Group chairman who put a staid and sprawling Indian conglomerate on the global stage with a string of high-profile acquisitions, has died, Tata Group said in a statement late on Wednesday. He was 86.
Source: www.reuters.comCategories: General Medicine News, Hem/OncsTweet-
One of greatest life honors when a few years ago touched the feet (take blessings) from this giant of human being who was tremendous champion of oncology (and so much more). Thank you Mr.Tata for what you have done for humanity 🙏🏽 Om Shanti Om. https://t.co/P8uxFfMQI1
-
-
Mashup Score: 11Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy - 11 month(s) ago
This post hoc analysis of the phase 3 SCOT randomized clinical trial investigates the association between the timing of adjuvant chemotherapy after surgery for colorectal cancer and disease-free survival.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
More on adjuvant timing. Will be interesting to 👀 surveillance ctDNA studies read out. Also, importance of ctDNA turn around time thinking of use cases. Improved plasma only approaches and/or workflows for tumor informed immediately post op https://t.co/GDnvLnNu9S
-
-
Mashup Score: 19Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment - 12 month(s) ago
Abstract. Purpose: Minimal residual disease (MRD) detection identifies patients with colorectal adenocarcinoma (CRC) likely to recur following definitive treatment. We evaluated a plasma only MRD assay to predict recurrence and survival in metastatic CRC patients undergoing curative intent procedures (surgery and/or radiotherapy), with or without (neo)adjuvant chemotherapy. The primary objective of this study was to assess the correlation of post-procedure tumor cfDNA detection status with radiographic disease recurrence (RFS). Experimental Design: Pre- and post-procedure longitudinal samples were collected from 53 patients and analyzed with a multiomic MRD assay detecting circulating tumor DNA (ctDNA) from genomic and epigenomic signals. Pre- and post-procedure ctDNA detection correlated with recurrence-free and overall survival. Results: 230/233 samples from 52 patients were successfully analyzed. At the time of data cutoff, 36 (69.2%) patients recurred with median follow-up of 31 mo
Source: aacrjournals.orgCategories: General Medicine News, Hem/OncsTweet-
As we started in 17, novelty not there but highlights a patient segment (oligomet CRC/ctDNA +) that needs options. Stay tuned for something we’re working on to broaden access to MRD trials! Plasma only (early version of guardant assay) in Oligomet CRC https://t.co/8jSXYs2Moz
-
-
Mashup Score: 15Guiding Principles for Community Building in Global Oncology - 12 month(s) ago
With the escalating incidence and prevalence of cancer worldwide disproportionately affecting low- and middle-income countries, there is an urgent need for the global oncology community to foster bidirectional partnerships and an equitable exchange of knowledge, resources, and expertise. A dedicated Global Oncology Community of Practice (CoP) can serve as a self-organizing, grassroots approach for members, with common goals and values, to coordinate efforts, maximize impact, and ensure sustainable outcomes. It is imperative, however, when outlining goals and priorities to adhere to an ethical and appropriate framework during community building efforts to avoid perpetuating inequities and power imbalances. This article reviews the core guiding principles for ASCO’s Global Oncology CoP which includes responsibility, amplification, accessibility, sustainability, and decolonization.
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
https://t.co/KDNC1KROoj @ASCO Global Oncology CoP
-
-
Mashup Score: 19
How a surprise diagnosis led him to found a youth basketball nonprofit.
Source: www.today.comCategories: General Medicine News, Oncologists1Tweet-
wallowing a bit after injury last weekend led to surgery this week & may prevent me from 🏃🏽♀️ @bostonmarathon but am so grateful despite the tiny setback & continually inspired by my patient’s resilience. You’re the best @MattMeyersohn @NinaMeyersohn https://t.co/qPq3xZu9yN
-
-
Mashup Score: 14Teacher Recalls Her First And Only Symptom Of Colon Cancer At 36 - 1 year(s) ago
What she thought was a stomach bug turned out to be cancer.
Source: www.today.comCategories: General Medicine News, Hem/OncsTweet-
Our patients have so much courage! So proud of this remarkable young patient of mine ❤️ @MGHCancerCenter https://t.co/FWhyNrzSin
-
-
Mashup Score: 68‘Where you live shouldn't determine how you get cancer’: An oncologist on global disparities - 1 year(s) ago
Cancer cases around the world are expected to surge 77% by 2050. A new WHO report highlights the disparities in mortality rates depending on income.
Source: www.statnews.comCategories: General Medicine News, Hem/OncsTweet-
Where you live directly impacts death from cancer (not surprising but incredibly sobering!) See numbers @WHO report. Discussed this disheartening data & some of things we are working on @MGHCancerCenter @MGHGlobalHealth @karkinoshealth @ASCO and others https://t.co/9s6zXwcFcK
-
-
Mashup Score: 35Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer - 1 year(s) ago
This cohort study examines the association of 1-month changes in patient-reported outcomes and serum tumor markers with treatment response and survival among patients with gastrointestinal cancer.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
Proud of our team https://t.co/8F70FRODdt Esp co 1st authors @jxj1998 (now in med school) @ASarafMD2 (new attending) for their incredible work. Started as 2017 office conversation w/ @RyanNipp when we said let’s do this. pros matter! ctDNA data coming next @MGHCancerCenter https://t.co/Clsm7RLr4o
-
-
Mashup Score: 9
Overview The NCI’s Cancer Diagnosis Program in the Division of Cancer Treatment and Diagnosis is hosting a workshop on circulating tumor DNA (ctDNA) in cancer treatment and clinical care. Previously, a workshop was held in 2016focused on promoting the translation of ctDNA assays into clinical research. In the intervening years, much progress has been made in the fast-evolving field of ctDNA, and clinical utility has been demonstrated.
Source: events.cancer.govCategories: Latest Headlines, Oncologists1Tweet-
💪🏽 start to day when you’re 1st in line at @dunkindonuts when it opens at 4:30 am @BostonLogan & line is already 50 ish people long. Thrilled to be @NCICancerCtrl for the 1st time for all things ctDNA. Amazing line up & excited for 2 days of learning https://t.co/nFKyNsEcqr
-
Asked to give a talk re ctDNA in CRC: Is it Ready for Primetime? The answer a yr ago would have been soon but fast forward a year, and it's a yes. I'll continue to try to convince people of this (& will also sneak in a run in beautiful Torrey Pines!) https://t.co/Q8evHlJyem